HealthInvest Partners’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Sell |
86,274
-5,027
| -6% | -$159K | 1.17% | 28 |
|
|
2025
Q1 | $3.03M | Sell |
91,301
-29,200
| -24% | -$969K | 1.34% | 23 |
|
|
2024
Q4 | $4.1M | Sell |
120,501
-31,374
| -21% | -$1.07M | 1.95% | 17 |
|
|
2024
Q3 | $6.08M | Buy |
151,875
+116,975
| +335% | +$4.68M | 2.86% | 15 |
|
|
2024
Q2 | $1.05M | Sell |
34,900
-135,100
| -79% | -$4.08M | 0.64% | 31 |
|
|
2024
Q1 | $5.71M | Buy |
170,000
+25,000
| +17% | +$840K | 3.47% | 6 |
|
|
2023
Q4 | $4.68M | Buy |
+145,000
| New | +$4.68M | 3.67% | 8 |
|
|
2022
Q3 | – | Sell |
-76,000
| Closed | -$3.71M | – | 12 |
|
|
2022
Q2 | $3.71M | Sell |
76,000
-44,000
| -37% | -$2.15M | 8.55% | 3 |
|
|
2022
Q1 | $5.84M | Sell |
120,000
-75,000
| -38% | -$3.65M | 9.3% | 5 |
|
|
2021
Q4 | $8.32M | Buy |
195,000
+10,000
| +5% | +$426K | 11.72% | 3 |
|
|
2021
Q3 | $7.09M | Buy |
+185,000
| New | +$7.09M | 10.62% | 4 |
|